Not exact matches
Jim Collins, a
biomedical engineer from Boston University not involved in the study, is interested in how the
research expands the
capabilities of genetic engineering.
This latter
capability is extremely valuable to
biomedical research, which relies heavily on fluorescent probes to label and track proteins, nucleic acids, and other cellular components.
The advanced
capabilities now available in CoMet are especially relevant to the needs of
biomedical research, clinical practice, natural product management, and environmental studies.